GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation

[1]  D. Salomon,et al.  Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways , 2022, Journal of experimental & clinical cancer research : CR.

[2]  M. Seno,et al.  MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway. , 2021, Biochemical and biophysical research communications.

[3]  J. Lathia,et al.  Cancer stem cell–immune cell crosstalk in tumour progression , 2021, Nature Reviews Cancer.

[4]  N. Okada,et al.  Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment , 2020, Scientific Reports.

[5]  M. Seno,et al.  Blood and Cancer: Cancer Stem Cells as Origin of Hematopoietic Cells in Solid Tumor Microenvironments , 2020, Cells.

[6]  M. Seno,et al.  A novel model of liver cancer stem cells developed from induced pluripotent stem cells , 2020, British Journal of Cancer.

[7]  Runan Yao,et al.  iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data , 2018, BMC Bioinformatics.

[8]  Hsiao-Mei Chao,et al.  Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research. , 2018, Journal of the Formosan Medical Association = Taiwan yi zhi.

[9]  L. Gan,et al.  Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways , 2018, Oncology reports.

[10]  Su-jin Kim,et al.  2i Maintains a Naive Ground State in ESCs through Two Distinct Epigenetic Mechanisms , 2017, Stem cell reports.

[11]  Wei Xiong,et al.  Role of tumor microenvironment in tumorigenesis , 2017, Journal of Cancer.

[12]  Fanglong Song,et al.  Mechanical Stress Regulates Osteogenesis and Adipogenesis of Rat Mesenchymal Stem Cells through PI3K/Akt/GSK-3β/β-Catenin Signaling Pathway , 2017, BioMed research international.

[13]  M. Seno,et al.  A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm). , 2016, American journal of cancer research.

[14]  G. Beatty,et al.  Immune Escape Mechanisms as a Guide for Cancer Immunotherapy , 2014, Clinical Cancer Research.

[15]  M. Hendrix,et al.  A Model of Cancer Stem Cells Derived from Mouse Induced Pluripotent Stem Cells , 2012, PloS one.

[16]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[17]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[18]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.